These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27547867)

  • 1. Recent Changes in Chronic Kidney Disease-Mineral and Bone Disorders and Associated Fractures After Kidney Transplantation.
    Perrin P; Kiener C; Javier RM; Braun L; Cognard N; Gautier-Vargas G; Heibel F; Muller C; Olagne J; Moulin B; Ohlmann S
    Transplantation; 2017 Aug; 101(8):1897-1905. PubMed ID: 27547867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Disease after Kidney Transplantation.
    Bouquegneau A; Salam S; Delanaye P; Eastell R; Khwaja A
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1282-1296. PubMed ID: 26912549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M
    Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D, parathyroid hormone, and bone mineral density status in kidney transplant recipients.
    Savaj S; Ghods FJ
    Iran J Kidney Dis; 2012 Jul; 6(4):295-9. PubMed ID: 22797100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with calcimimetics in kidney transplantation.
    Morales E; Gutierrez E; Andres A
    Transplant Rev (Orlando); 2010 Apr; 24(2):79-88. PubMed ID: 20303456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of kidney transplantation on bone.
    Kodras K; Haas M
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():63-75. PubMed ID: 16884399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
    Borrego Utiel FJ; Bravo Soto JA; Merino Pérez MJ; González Carmelo I; López Jiménez V; García Álvarez T; Acosta Martínez Y; Mazuecos Blanca MA
    Nefrologia; 2015; 35(4):363-73. PubMed ID: 26306956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cinacalcet cessation on hyperparathyroidism in kidney transcaplant patients after long-term dialysis therapy.
    Nakai K; Fujii H; Yoshikawa M; Kono K; Yonekura Y; Goto S; Ishimura T; Takeda M; Fujisawa M; Nishi S
    Clin Exp Nephrol; 2015 Dec; 19(6):1184-8. PubMed ID: 25782729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation.
    Perrin P; Caillard S; Javier RM; Braun L; Heibel F; Borni-Duval C; Muller C; Olagne J; Moulin B
    Am J Transplant; 2013 Oct; 13(10):2653-63. PubMed ID: 24034142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for nonvertebral bone fractures in kidney transplant recipients - a single-center retrospective analysis.
    Jerman A; Lindič J; Škoberne A; Borštnar Š; Martinuč Bergoč M; Godnov U; Kovač D
    Clin Nephrol; 2017 Supplement 1; 88(13):101-108. PubMed ID: 28655391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of successful renal transplant to produce appropriate levels of 1,25-dihydroxyvitamin D.
    Fleseriu M; Licata AA
    Osteoporos Int; 2007 Mar; 18(3):363-8. PubMed ID: 17061149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.
    Joy MS; Karagiannis PC; Peyerl FW
    J Manag Care Pharm; 2007 Jun; 13(5):397-411. PubMed ID: 17605511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and management of bone disease and fractures post transplant.
    Bia M
    Transplant Rev (Orlando); 2008 Jan; 22(1):52-61. PubMed ID: 18631858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the risk of re-fracture in the dialysis population: is it time to consider therapy with PTH analogues?
    Jamal SA; Hodsman AB
    Semin Dial; 2011; 24(1):12-5. PubMed ID: 21299630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic bone disease after renal transplantation.
    Haffner D; Schüler U
    Curr Opin Pediatr; 2014 Apr; 26(2):198-206. PubMed ID: 24535492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant Osteoporosis and Osteopenia are Risk Factors for Fractures After Kidney Transplantation.
    Lee ES; Lim JH; Cho JH; Jung HY; Choi JY; Park SH; Kim YL; Ro H; Lee S; Han SY; Jung CW; Park JB; Kim MS; Yang J; Ahn C; Kim CD;
    Transplant Proc; 2019 Oct; 51(8):2704-2709. PubMed ID: 31477421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture risk after parathyroidectomy among chronic hemodialysis patients.
    Rudser KD; de Boer IH; Dooley A; Young B; Kestenbaum B
    J Am Soc Nephrol; 2007 Aug; 18(8):2401-7. PubMed ID: 17634437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.